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Abstract 
Chlamydia trachomatis is an obligate intracellular parasite and the leading cause of 
sexually transmitted bacterial infections in the human urogenital tract. Clinical 
manifestations of chlamydial infection include urethritis, cervicitis, pelvic 
inflammatory disease and tubal factor infertility. These pathological conditions are 
caused by the immune response to both acute and chronic chlamydial infections. 
Evidence suggests a high proportion of infections remain subclinical until 
spontaneous resolution or the commencement of symptoms leads to a diagnosis. 
Therefore, a substantial proportion of the morbidity and burden associated with 
chlamydia can likely be attributed to unresolved and untreated infections. While 
treatment with azithromycin is highly effective, treatment failure does occur. The 
mechanisms of treatment failure and its effects on fertility are poorly understood. 
Unlike other bacterial pathogens, C. trachomatis lacks stable genotypic resistance to 
macrolides. Another key difference between Chlamydia and many other bacteria is the 
constant interaction with its host cell. Thus, it was hypothesised that the unique 
intracellular niche and developmental cycle of C. trachomatis are important microbial 
factors which could affect treatment efficacy. To test this, several host and chlamydial 
factors were investigated. 16S rRNA gene amplicon sequencing of vaginal and 
cervical swabs and endometrial biopsies from participants of a case -control fertility 
study revealed that similarities in the microbial populat ions of the vagina and cervix 
were not predictive of those in the endometrium. While there was no association 
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between microbial community compositions and fertility status identified, Ureaplasma 
spp. were overrepresented amongst infertile women. The endometrial expression of 
several genes involved in immunity and reproductive function showed no association 
with microbial community composition, however, the gene which encodes tenascin-C 
was over-expressed in women who had a self-reported history of miscarriage. 
Comparisons of clinical isolates from women treated for chlamydial infections 
showed no significant differences in developmental or stress phenotypes but suggested 
that the subtle differences observed using in vitro models may not truly reflect the 
complexity of in vivo infectious processes. Finally, analysis of host and chlamydial 
gene expression before and after antibiotic treatment showed no association with 
outcome but yielded valuable information about the host and pathogen during the 
period following treatment. In particular, chlamydial gene expression was upregulated 
after they had survived treatment with azithromycin. This project has contributed 
towards current knowledge and increases the field‟s understanding of the host and 
chlamydial factors involved in treatment failure and infertility. Additionally, it 
provides insight for future investigations of these important and complex interactions 
between humans and the bacteria which have evolved alongside us.     
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